| Old Articles: <Older 23521-23530 Newer> |
 |
The Motley Fool May 25, 2007 Tom Taulli |
CA's Return to Normalcy The once-troubled software company is putting in place the ingredients for growth. Investors, take note.  |
The Motley Fool May 25, 2007 Brian Orelli |
Amylin Sifts for Gold The biotech mines extra value from its compound library. Investors, take note.  |
The Motley Fool May 25, 2007 Mike Cianciolo |
Up, Up, and Away With Aeropostale: Fool by Numbers The mall retailer released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool May 25, 2007 Rick Aristotle Munarriz |
Maverick Defies the Pack Cedar Fair's new coaster is both early and late. What will it mean to investors?  |
The Motley Fool May 25, 2007 Mike Cianciolo |
Aeropostale Trending Higher The retailer raises guidance after an impressive first quarter. Investors, take note.  |
The Motley Fool May 25, 2007 Matt Koppenheffer |
Fool on the Street: Comerica's Growth Markets The firm is bringing its style of banking to new high-growth markets. Judging by metrics such as return on equity and assets, Comerica may very well be on to something with its current strategy. Investors, take note.  |
The Motley Fool May 25, 2007 |
Gap Presses On: Fool by Numbers The retailer released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool May 25, 2007 Timothy M. Otte |
Shoe Carnival Stubs Its Toe The value shoe retailer fails to impress in the first quarter. With the industry going through a consolidation phase, this could be an opportunity for value investors to begin averaging in.  |
The Motley Fool May 25, 2007 Brian Lawler |
Bristol-Myers Tries to Boost Abilify Bristol-Myers announces new data for one of its top compounds. Investors, take note.  |
The Motley Fool May 25, 2007 Emil Lee |
Fool on the Street: Marshall & Ilsley's Hidden Treasure? The Midwest bank's Metavante spinoff is worth a look from investors.  |
| <Older 23521-23530 Newer> Return to current articles. |